[go: up one dir, main page]

Li et al., 2020 - Google Patents

The main bottleneck for non-metastatic pancreatic adenocarcinoma in past decades: A population-based analysis

Li et al., 2020

View HTML
Document ID
9330131886756323935
Author
Li Y
Liu W
Zhao L
Xu Y
Yan T
Yang Q
Pei Q
Güngör C
Publication year
Publication venue
Medical science monitor: international medical journal of experimental and clinical research

External Links

Snippet

Background Despite recent advancements in surgical techniques, chemotherapy, and radiotherapy, the 5-year survival rate of patients with pancreatic ductal adenocarcinoma (PDAC) remains an unsatisfactory~ 8%. Material/Methods Data were extracted to identify …
Continue reading at pmc.ncbi.nlm.nih.gov (HTML) (other versions)

Similar Documents

Publication Publication Date Title
Deeb et al. Pulmonary metastases in pancreatic cancer, is there a survival influence?
Carrato Adjuvant treatment of colorectal cancer
Idachaba et al. A review of pancreatic cancer: epidemiology, genetics, screening, and management
Shintani et al. Prognostic significance of serum CEA for non-small cell lung cancer patients receiving stereotactic body radiotherapy
Luo et al. Radiotherapy for esophageal carcinoma: dose, response and survival
Boimel et al. Proton beam reirradiation for locally recurrent pancreatic adenocarcinoma
Holman et al. Results of intraoperative electron beam radiotherapy containing multimodality treatment for locally unresectable T4 rectal cancer: a pooled analysis of the Mayo Clinic Rochester and Catharina Hospital Eindhoven
Yu et al. Accuracy of magnetic resonance imaging in staging rectal cancer with multidisciplinary team: a single-center experience
Wang et al. Long-term survival results of patients with locally advanced gastric cancer and pathological complete response after neoadjuvant chemotherapy and resection
Li et al. Chemoradiotherapy for synchronous multiple primary cancers with esophageal squamous cell carcinoma: a case-control study
Sherman et al. Predictors of response and survival in locally advanced adenocarcinoma of the pancreas following neoadjuvant GTX with or without radiation therapy
Zeng et al. Clinicopathological risk factors in the light of the revised 2018 International Federation of Gynecology and Obstetrics staging system for early cervical cancer with staging IB: a single center retrospective study
Li et al. Evaluation of hepatectomy and palliative local treatments for gastric cancer patients with liver metastases: a propensity score matching analysis
Fares et al. Complete metastasectomy in renal cell carcinoma: a propensity-score matched by the International Metastatic RCC Database Consortium prognostic model
Wang et al. Salvage lymphadenectomy for isolated cervical lymph node recurrence after curative resection of thoracic esophageal squamous cell carcinoma
Xu et al. Survival prediction for non-small cell lung cancer patients treated with CT-guided microwave ablation: development of a prognostic nomogram
Li et al. The main bottleneck for non-metastatic pancreatic adenocarcinoma in past decades: A population-based analysis
Zhu et al. Postoperative radiation in esophageal squamous cell carcinoma and target volume delineation
Shi et al. Definitive chemoradiotherapy and salvage chemotherapy for patients with isolated locoregional recurrence after radical resection of primary pancreatic cancer
Ma et al. Impact of adjuvant therapy in patients with a microscopically positive margin after resection for gastric and esophageal cancers
Goel et al. Multimodality management of gallbladder cancer can lead to a better outcome: Experience from a tertiary care oncology centre in North India
Kim et al. Prognostic significance of the lymph node ratio regarding recurrence and survival in rectal cancer patients treated with postoperative chemoradiotherapy
Farooq et al. Multiregion comprehensive genomic profiling of a gastric mixed neuroendocrine-nonneuroendocrine neoplasm with trilineage differentiation
Wang et al. Graded histologic response after neoadjuvant chemotherapy is an optimal criterion for treatment change in patients with locally advanced gastric cancer
Sun et al. Elective nodal irradiation or involved-field irradiation in definitive chemoradiotherapy for esophageal squamous cell cancer: a retrospective analysis in clinical N0 patients